Cecelia R Miller

7PUBLICATIONS
49CO-AUTHORS
Haematological tumoursGene and molecular therapyEpigenetics (incl. genome methylation and epigenomics)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 25, 2026
Outcomes of patients with chronic lymphocytic leukemia discontinuing covalent Bruton tyrosine kinase inhibitors due to adverse events.

|Dec 19, 2025
Combining Brigatinib with mTOR Inhibition to Effectively Treat NF2-SWN-Associated and Sporadic NF2-Deficient Meningiomas.

Long-Sheng Chang, Janet L Oblinger, Lai Man Natalie Wu

|Sep 19, 2025
Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study.

Andrea Visentin, Enrico Gaffo, Moritz Fürstenau

|Jul 02, 2025
Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era.

Cecelia R Miller, Ying Huang, John N Allan

|Feb 20, 2024
Comparison of karyotype scoring guidelines for evaluating karyotype complexity in chronic lymphocytic leukemia.

Matthew R Avenarius, Ying Huang, Adam S Kittai

|Oct 18, 2023
Characteristics and outcomes of patients with CLL and CDKN2A/B deletion by fluorescence in situ hybridization.

Samantha M Teierle, Ying Huang, Adam S Kittai

Pageof 2

Frequent Collaborators

4 joint publications

Jennifer A Woyach

1 joint publications

Andrea Visentin

1 joint publications

Enrico Gaffo

1 joint publications

Moritz Fürstenau